# Trial Using Gilotrif for Advanced Penile Squamous Cell Carcinoma

> **NCT02541903** · PHASE2 · TERMINATED · sponsor: **University of Alabama at Birmingham** · enrollment: 8 (actual)

## Conditions studied

- Penile Squamous Cell Carcinoma (PSCC)

## Interventions

- **DRUG:** Gilotrif

## Key facts

- **NCT ID:** NCT02541903
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-10
- **Primary completion:** 2019-01-26
- **Final completion:** 2020-04
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** poor overall accrual
- **Last updated:** 2020-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02541903

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02541903, "Trial Using Gilotrif for Advanced Penile Squamous Cell Carcinoma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02541903. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*